tiprankstipranks
Advertisement
Advertisement

AU:NOX Stock Latest News

Noxopharm Data Backs SOF-16’s Anti-Inflammatory Potential in Autoimmune Disease
Company AnnouncementsNoxopharm Data Backs SOF-16’s Anti-Inflammatory Potential in Autoimmune Disease
3d ago
NOX
Noxopharm Names CFO Shawn van Boheemen as New Company Secretary
PremiumCompany Announcements
Noxopharm Names CFO Shawn van Boheemen as New Company Secretary
4d ago
NOX
Noxopharm deepens Sofra push with Tezcat deal, CEO shift and key trial progress
PremiumCompany Announcements
Noxopharm deepens Sofra push with Tezcat deal, CEO shift and key trial progress
10d ago
NOX
Noxopharm’s SOF-SKN shows prolonged skin retention in preclinical study
PremiumCompany Announcements
Noxopharm’s SOF-SKN shows prolonged skin retention in preclinical study
12d ago
NOX
Noxopharm Tightens Disclosure Controls After CEO Resigns and Director Notices Updated
PremiumCompany Announcements
Noxopharm Tightens Disclosure Controls After CEO Resigns and Director Notices Updated
19d ago
NOX
Noxopharm CEO Resigns as Biotech Awaits Successor Amid Strategic Shift
PremiumCompany AnnouncementsNoxopharm CEO Resigns as Biotech Awaits Successor Amid Strategic Shift
20d ago
NOX
Noxopharm Half-Year Loss Widens as Net Tangible Assets Turn Negative
Premium
Company Announcements
Noxopharm Half-Year Loss Widens as Net Tangible Assets Turn Negative
2M ago
NOX
Noxopharm Issues 15 Million New Shares Under Financing Facility
Premium
Company Announcements
Noxopharm Issues 15 Million New Shares Under Financing Facility
2M ago
NOX
Noxopharm Issues 15 Million New Shares Under Financing Facility
PremiumCompany Announcements
Noxopharm Issues 15 Million New Shares Under Financing Facility
2M ago
NOX
Noxopharm Secures $2.8m R&D Rebate to Advance Sofra Clinical Programs
PremiumCompany Announcements
Noxopharm Secures $2.8m R&D Rebate to Advance Sofra Clinical Programs
2M ago
NOX
Noxopharm Secures Flexible $5m At-the-Market Equity Facility with Acuity Capital
PremiumCompany Announcements
Noxopharm Secures Flexible $5m At-the-Market Equity Facility with Acuity Capital
2M ago
NOX
Noxopharm’s Sofra Platform Science Published in Top Immunology Journal
PremiumCompany Announcements
Noxopharm’s Sofra Platform Science Published in Top Immunology Journal
3M ago
NOX
Noxopharm Clears Key Safety Milestone as HERACLES Trial Concludes and Sofra Platform Gains Global Traction
PremiumCompany AnnouncementsNoxopharm Clears Key Safety Milestone as HERACLES Trial Concludes and Sofra Platform Gains Global Traction
3M ago
NOX
Noxopharm Clears Safety Milestone as HERACLES Trial for SOF-SKN Concludes
Premium
Company Announcements
Noxopharm Clears Safety Milestone as HERACLES Trial for SOF-SKN Concludes
3M ago
NOX
Noxopharm Rolls Over $2.6m in Convertible Notes, Flagging Potential Share Dilution
Premium
Company Announcements
Noxopharm Rolls Over $2.6m in Convertible Notes, Flagging Potential Share Dilution
4M ago
NOX
Noxopharm Issues New Unquoted Options and Convertible Notes
PremiumCompany Announcements
Noxopharm Issues New Unquoted Options and Convertible Notes
4M ago
NOX
Noxopharm Redeems 2.6 Million Convertible Notes, Trimming Convertible Debt
PremiumCompany Announcements
Noxopharm Redeems 2.6 Million Convertible Notes, Trimming Convertible Debt
4M ago
NOX
Noxopharm Ltd. Announces Director’s Interest Change
PremiumCompany Announcements
Noxopharm Ltd. Announces Director’s Interest Change
5M ago
NOX
Noxopharm Issues Convertible Notes to Restructure Capital
PremiumCompany Announcements
Noxopharm Issues Convertible Notes to Restructure Capital
5M ago
NOX
Noxopharm Ltd. Issues New Equity Securities to Bolster Growth
PremiumCompany AnnouncementsNoxopharm Ltd. Issues New Equity Securities to Bolster Growth
5M ago
NOX
Noxopharm Advances SOF-SKN™ Clinical Trial for Autoimmune Diseases
Premium
Company Announcements
Noxopharm Advances SOF-SKN™ Clinical Trial for Autoimmune Diseases
5M ago
NOX
Noxopharm’s AGM Resolutions Passed, Highlighting Growth Potential of Sofra Platform
Premium
Company Announcements
Noxopharm’s AGM Resolutions Passed, Highlighting Growth Potential of Sofra Platform
6M ago
NOX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >